Market Overview:
The global live cell encapsulation market is expected to grow at a CAGR of XX% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing prevalence of chronic diseases, rising demand for minimally invasive treatments, and technological advancements in live cell encapsulation products. Based on type, the global live cell encapsulation market is segmented into alginate, chitosan, cellulose, and others. Alginate dominates the market due to its biocompatibility and non-toxicity. Chitosan is also gaining popularity due to its ability to form a strong gel matrix that can protect cells from shear forces and degradation. Based on application, the global live cell encapsulation market is segmented into diabetes mellitus, cancer therapy & research (oncology), epilepsy treatment & research (neurology), Parkinson’s disease treatment & research (neurology), and others. Diabetes mellitus held majority share of this segment in 2017 owing to increasing incidence of diabetes across the globe.
Product Definition:
Live cell encapsulation is the process of enclosing live cells in a semipermeable membrane. This membrane allows for the exchange of nutrients and waste products between the cells and their environment. The importance of live cell encapsulation lies in its ability to protect cells from harsh environments and to promote cellular growth.
Alginate:
Alginate is a polymer of galactose & mannose with an average molecular weight of around 5,500. It has several properties such as water-solubility, viscosity and gelation temperature. Alginates are used in the formulation of various food additives and excipients which include emulsifiers, stabilizers, thickeners and gelling agents among others.
Chitosan:
Chitosan is a polysaccharide polymer with an amino group and a hydroxyl group. It has the ability to form highly organized nanofibers that can be used for cell encapsulation. The most commonly used chitosan in the market is derived from crab, lobster, shrimp, and crayfish shells.
Application Insights:
The application segment comprises of diabetes, cancer, epilepsy, Parkinson¢â‚¬â„¢s disease and others. Diabetes is expected to be the fastest-growing segment over the forecast period owing to increasing prevalence of diabetes and rising demand for encapsulation products in diabetic therapies.
Cellulose acetate hemihydrate (CAH) was the most widely used product in encapsulation applications followed by alginate based systems due to their low cost nature as compared with other polymers such as gelatin or chitosan. The use of these two hydrogels offers advantages such as biocompatibility along with easy handling & processing characteristics required for large scale production which are likely to propel their demand in various end-use industries during the forecast period.
Regional Analysis:
North America dominated the global market in 2017. The region is expected to maintain its position during the forecast period due to high awareness levels regarding cancer and other diseases, availability of advanced technologies, and presence of a large number of players operating in this region. Asia Pacific is estimated to be the fastest-growing regional market over the forecast period owing to increasing focus on research activities by various organizations such as Indian Council of Medical Research (ICMR) and Ministry Of Health And Family Welfare, Government Of India. This has led to an increase in funding for R&D activities related Encapsulin Technology in this region which will drive growth further.
The key companies operating within Asia Pacific are Shandong Jiaa Biochemical Co., Ltd.
Growth Factors:
- Increasing demand for regenerative medicine
- Rising prevalence of chronic diseases
- Technological advancements in live cell encapsulation products and devices
- Growing number of clinical trials for live cell encapsulation therapies
- Rising healthcare expenditure
Scope Of The Report
Report Attributes
Report Details
Report Title
Live Cell Encapsulation Market Research Report
By Type
Alginate, Chitosan, Cellulose, Others
By Application
Diabetes, Cancer, Epilepsy, Parkinson, Others
By Companies
Viacyte, Inc., Living Cell Technologies Ltd., Sigilon Therapeutics, Inc, Sernova Corporation, PharmaCyte Biotech Inc, Gloriana Therapeutics, Kadimastem, Beta-O2 Technologies, Inc., Altucell, Inc., Diatranz Otsuka Ltd
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
145
Number of Tables & Figures
102
Customization Available
Yes, the report can be customized as per your need.
Global Live Cell Encapsulation Market Report Segments:
The global Live Cell Encapsulation market is segmented on the basis of:
Types
Alginate, Chitosan, Cellulose, Others
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diabetes, Cancer, Epilepsy, Parkinson, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Viacyte, Inc.
- Living Cell Technologies Ltd.
- Sigilon Therapeutics, Inc
- Sernova Corporation
- PharmaCyte Biotech Inc
- Gloriana Therapeutics
- Kadimastem
- Beta-O2 Technologies, Inc.
- Altucell, Inc.
- Diatranz Otsuka Ltd
Highlights of The Live Cell Encapsulation Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Alginate
- Chitosan
- Cellulose
- Others
- By Application:
- Diabetes
- Cancer
- Epilepsy
- Parkinson
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Live Cell Encapsulation Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Live cell encapsulation is a process of enclosing cells in a protective membrane to prevent them from being damaged or destroyed.
Some of the key players operating in the live cell encapsulation market are Viacyte, Inc., Living Cell Technologies Ltd., Sigilon Therapeutics, Inc, Sernova Corporation, PharmaCyte Biotech Inc, Gloriana Therapeutics, Kadimastem, Beta-O2 Technologies, Inc., Altucell, Inc., Diatranz Otsuka Ltd.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Live Cell Encapsulation Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Live Cell Encapsulation Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Live Cell Encapsulation Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Live Cell Encapsulation Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Live Cell Encapsulation Market Size & Forecast, 2020-2028
4.5.1 Live Cell Encapsulation Market Size and Y-o-Y Growth
4.5.2 Live Cell Encapsulation Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Alginate
5.2.2 Chitosan
5.2.3 Cellulose
5.2.4 Others
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Diabetes
6.2.2 Cancer
6.2.3 Epilepsy
6.2.4 Parkinson
6.2.5 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Live Cell Encapsulation Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Live Cell Encapsulation Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Alginate
9.6.2 Chitosan
9.6.3 Cellulose
9.6.4 Others
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Diabetes
9.10.2 Cancer
9.10.3 Epilepsy
9.10.4 Parkinson
9.10.5 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Alginate
10.6.2 Chitosan
10.6.3 Cellulose
10.6.4 Others
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Diabetes
10.10.2 Cancer
10.10.3 Epilepsy
10.10.4 Parkinson
10.10.5 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Alginate
11.6.2 Chitosan
11.6.3 Cellulose
11.6.4 Others
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Diabetes
11.10.2 Cancer
11.10.3 Epilepsy
11.10.4 Parkinson
11.10.5 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Alginate
12.6.2 Chitosan
12.6.3 Cellulose
12.6.4 Others
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Diabetes
12.10.2 Cancer
12.10.3 Epilepsy
12.10.4 Parkinson
12.10.5 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Alginate
13.6.2 Chitosan
13.6.3 Cellulose
13.6.4 Others
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Diabetes
13.10.2 Cancer
13.10.3 Epilepsy
13.10.4 Parkinson
13.10.5 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Live Cell Encapsulation Market: Competitive Dashboard
14.2 Global Live Cell Encapsulation Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Viacyte, Inc.
14.3.2 Living Cell Technologies Ltd.
14.3.3 Sigilon Therapeutics, Inc
14.3.4 Sernova Corporation
14.3.5 PharmaCyte Biotech Inc
14.3.6 Gloriana Therapeutics
14.3.7 Kadimastem
14.3.8 Beta-O2 Technologies, Inc.
14.3.9 Altucell, Inc.
14.3.10 Diatranz Otsuka Ltd
